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During cycling between the tick vector and a mammal, the Lyme disease spirochaete Borrelia
burgdorferi must coordinate expression of outer-surface proteins (Osps) A and B to quickly
respond to environmental changes. The pathogen abundantly produces OspA/B in the tick, but
represses their expression during mammalian infection. This paper reports a regulatory structure,
consisting of two sequences flanking the ospAB promoter, that is required for enhancing ospA
expression in B. burgdorferi grown in vitro, but repressing its expression during murine infection.
Deletion or replacement of either the upstream or downstream sequence of the ospAB promoter
caused a significant decrease in ospA expression in vitro, but a dramatic increase during murine
infection. Fusion of either sequence with the flaB reporter promoter led to increased expression of
an ospA reporter gene in vitro, but a decrease in the murine host. Furthermore, simultaneous
fusion of both sequences with the reporter promoter showed a synergistic effect in enhancing
expression of the ospA reporter in vitro, but repressing its expression during murine infection.
Taken together, the results demonstrate that the regulatory structure functions oppositely in the
two different environments and potentially provides B. burgdorferi with a molecular mechanism to
quickly adapt to the distinct environments during its enzootic life cycle.
INTRODUCTION
Outer-surface proteins (Osps) A and B, encoded by a two-
gene operon (Howe et al., 1986), are the surface antigens
most abundantly produced by the Lyme disease spirochaete
Borrelia burgdorferi in engorged and unfed Ixodes ticks (de
Silva et al., 1996; Ohnishi et al., 2001; Schwan et al., 1995;
Schwan & Piesman, 2000). In response to a fresh blood
meal, B. burgdorferi downregulates OspA/B and upregu-
lates OspC and other Osps, a process that prepares the
spirochaete for infection of a mammal (Fingerle et al.,
2007; Grimm et al., 2004; Pal et al., 2004b; Stewart et al.,
2006). Repressing ospAB expression during mammalian
infection is critical for B. burgdorferi to evade the immune
system, cause persistent infection and maintain the
enzootic cycle, as OspA and OspB, even expressed at a
low level, may ultimately induce a strong specific humoral
response owing to their high immunogenicity. The specific
response can impose tremendous pressure on the pathogen
or clear the infection (Strother et al., 2007; Xu et al.,
2008a). Even though the anti-OspA/B response may not
effectively target spirochaetes with low OspA/B production
in mammalian tissues, once acquired by the tick vector, the
pathogen dramatically upregulates OspA/B and becomes
extremely vulnerable to anti-OspA/B antibodies in a blood
meal (de Silva et al., 1997; Tsao et al., 2001, 2004),
potentially leading to the eradication of the organism and
consequently to discontinuation of the enzootic cycle.
Expression of the ospAB operon is driven by a s
70-
dependent promoter (Sohaskey et al., 1999); thus, B.
burgdorferi cannot shut off this major sigma factor in order
to achieve the downregulation of OspA/B. Sohaskey et al.
(1999) showed that deletion of the T-rich region
immediately upstream of the ospAB promoter resulted in
greatly reduced expression of a chloramphenicol acetyl-
transferase reporter gene in B. burgdorferi grown in vitro.
Caimano et al. (2005) showed that the downregulation of
OspA requires RpoS production and proposed a model for
RpoS-dependent in vivo repression of ospA, which involves
an unknown repressor protein or an unknown cofactor
that can bind RpoS and an unidentified sequence within
the ospAB promoter (Caimano et al., 2005). Later, the
group further suggested that the T-rich region immediately
Abbreviations: DR, direct repeat; Osp, outer-surface protein; SCID,
severe combined immunodeficiency; RT, reverse transcription; qPCR,
quantitative PCR.
Two supplementary tables with details of the constructs, clones and
plasmids used in this study are available with the online version of this
paper.
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(Caimano et al., 2007).
In spite of this progress, it remains largely unknown how B.
burgdorferi can so effectively down- and upregulate ospAB
during its enzootic cycle. The present study focused on
sequences both upstream and downstream of the ospAB
promoter, and successfully identified two cis elements,
which are involved in ospAB regulation by B. burgdorferi
grown in vitro as well as during murine infection.
METHODS
Previously generated strains and constructs used in the
current study. Clones 13A and 13A/E22/C and the ospA mutant,
DospA, were generated previously (Xu et al., 2007a, b, 2008b). The
constructs pBBE22-CpospA and pBBE22-ospA9 were constructed in an
earlier study (Xu et al., 2008b). The shuttle vector pBBE22 and the B.
burgdorferi B31 clone 5A11 were kindly provided by S. Norris (Purser
& Norris, 2000; Purser et al., 2003). The features of these clones and
constructs are summarized in Supplementary Table S1, available with
the online version of this paper.
Creation of the constructs pBBE22-ospA1 to pBBE22-ospA7.
The seven constructs were generated as illustrated in Fig. 1. Briefly,
three amplicons, ospA1 (1085 bp), ospA2 (958 bp) and ospA3
(925 bp), were generated by PCR using forward primers P1F, P2F
and P3F (Supplementary Table S2), respectively, and a common
reverse primer, P1R, with borrelial DNA as template. The resulting
products were digested with the restriction enzymes BamHI and XbaI,
purified, and cloned into the shuttle vector pBBE22, digested with the
same enzymes. The inserts and their flanking regions were sequenced
to ensure they were arranged as designed. The three constructs were
designated pBBE22-ospA1, pBBE22-ospA2 and pBBE22-ospA3.
As illustrated in Fig. 2(A), the fragment ospA4 was directly amplified
from the construct pBBE22-CpospA with use of primers P4F and P1R
(Supplementary Table S2). The long primer, P4F, incorporated the
235 and 210 regions of the ospAB promoter, and the sequence
between them (Supplementary Table S2).
To generate the fragment ospA5 (Fig. 2B), two amplicons were
generated from the construct pBBE22-ospA1 with use of primers P5F
and P5R, and from the construct pBBE22-ospA9 with primers P6F and
P6R (Supplementary Table S2), respectively. The resulting amplicons
were fused via blunt-end ligation and further amplified with use of
primers P1F and P1R to introduce BamHI and XbaI restriction
enzyme sites at the ends.
To construct ospA6 (Fig. 2C), two amplicons were generated from the
construct pBBE22-ospA9 with the use of primer pairs P5F and P7R,
and P7F and P6R (Supplementary Table S2), respectively. The
resulting amplicons were digested with AseI, ligated and amplified
using primers P8F and P1R, to introduce BamHI and XbaI restriction
enzyme sites at the ends.
To create the fragment ospA7 (Fig. 2D), two amplicons were generated
from the construct pBBE22-ospA1 with the use of primers P5F and
P5R, and from the construct pBBE22-ospA6 using primers P6F and
P6R, respectively. The resulting amplicons were fused via blunt-end
ligation and further amplified with the use of primers P1F and P1R to
introduce BamHI and XbaI restriction enzyme sites at the ends.
Fragments ospA4, ospA5, ospA6 and ospA7 were cloned into pBBE22,
to complete the creation of the constructs pBBE22-ospA4, pBBE22-
ospA5, pBBE22-ospA6 and pBBE22-ospA7 (Fig. 1B). The inserts and
flanking regions were sequenced to ensure that the constructs were
created as designed.
Transformation of B. burgdorferi and selection of transfor-
mants. Constructs were electroporated into the DospA mutant; the
resultingtransformants were screenedand analysed for plasmid content
as described previously (Xu et al.,2 0 0 5 ) .R e s t o r a t i o no fO s p A
production was verified using immunoblots probed with a mixture of
FlaB and OspA mAbs, asdescribed inan earlier study (Xu et al.,2 0 0 8 b ) .
Constructs were also electroporated into clone 13A spirochaetes; the
resulting transformants were screened and selected as described
above, but immunoblotting was not performed because overwhelm-
ing OspA production from the native ospA copy potentially masked
the contribution from introduced constructs.
Mouse infection. Severe combined immunodeficiency (SCID) mice
(BALB/c background; age 4–8 weeks; provided by the LSU Division of
Laboratory Animal Medicine) were given a single intradermal/
subcutaneous injection of 10
4 spirochaetes. Animals were examined
for the development of arthritis at 2 day intervals, starting at day 7,
and sacrificed 1 month post-inoculation. If no significant joint
swelling was noted, heart, joint and skin samples were subjected to
spirochaetal isolation as described previously (Xu et al., 2005). If joint
swelling was apparent, skin, joint and heart specimens were collected
for RNA preparation. RNA was converted to cDNA by reverse
transcription (RT) and quantified for the mRNA copy numbers of
flaB and ospA by quantitative PCR (qPCR) as described previously
(Liang et al., 2004a). The animal procedures described here were
approved by the Institutional Animal Care and Use Committee at
Louisiana State University.
Statistical analysis. Data were first analysed by using a one-way
analysis of variance when an experiment involved more than two
groups. A two-tailed Student t test was used to compare two
treatments and calculate P-values. Calculated P-values of ¡0.05 were
considered significant.
RESULTS
Generation of constructs
A total of seven constructs, pBBE22-ospA1 to pBBE22-
ospA7, were generated from the shuttle vector pBBE22.
pBBE22 was modified from pBSV2 by inserting a copy of
bbe22, a gene that codes for a nicotinamidase essential for
the basic survival of B. burgdorferi in mammalian hosts
(Purser et al., 2003; Stewart et al., 2001). Because the B.
burgdorferi B31 clone 13A, which lacks lp25 and lp56 (Xu
et al., 2007a), was used as the parental strain in the current
study, constructs harbouring bbe22 were required for
restoration of infectivity of its derivatives.
Deletion of the direct repeats and the T-rich
region leads to decreased ospA expression in
vitro but increased expression in mice
Three constructs, pBBE22-ospA1 to pBBE22-ospA3, were
first electroporated into DospA; between 11 and 20
transformants were obtained from transformation with
each construct. Plasmid content analyses led to the
selection of two clones containing each construct. The
six clones, DospA/ospA1/1, DospA/ospA1/2, DospA/ospA2/1,
ospAB regulatory elements
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the same plasmid content as DospA, which had lost cp9,
lp5, lp21, lp28-1, lp25 and lp56 (Xu et al., 2008b). An
immunoblot analysis showed that all transformants
abundantly produced OspA (Fig. 3A).
To precisely compare the ospA expression activity driven by
each construct, the DospA/ospA1/1, DospA/ospA1/2, DospA/
ospA2/1, DospA/ospA2/2, DospA/ospA3/1 and DospA/ospA3/2
spirochaetes were harvested at late-exponential phase (10
8
cells ml
21). RNA was prepared and analysed for ospA
and flaB mRNA copies by RT-qPCR. As shown in
Fig. 3(B), the pBBE22-ospA1 spirochaetes accumulated
17% and 29% more ospA transcripts than the genotypes
pBBE22-ospA2 (P,0.05) and pBBE22-ospA3 (P59.2610
23),
respectively. Moreover, the genotype pBBE22-ospA2 produced
Fig. 1. Generation of constructs. (A) Potential regulatory sequences upstream of the coding region of the ospAB operon,
including a pair of direct repeats, DR1 and DR2 (labelled with long arrows), a T-rich region (underlined with a solid line), and a
sequence between the ”10 region and the start codon ATG (underlined with a dotted line). The ”35 and ”10 regions, putative
ribosome-binding site (RBS), start codon ATG, and stop codon TAA (all in bold type) are indicated. The +1 marks the
previously identified transcriptional initiation site (Jonsson et al., 1992). The amplification start sites of primers P1F, P2F, P3F
and P1R, designed for amplifying the fragments ospA1, ospA2 and ospA3, are marked with vertical lines. (B) Generation of
constructs pBBE22-ospA1 to pBBE22-ospA7. Three amplicons, ospA1, ospA2 and ospA3, were generated by PCR using
forward primers P1F, P2F and P3F, respectively, and a common reverse primer P1R, with borrelial DNA as a template, and
cloned into the shuttle vector pBBE22. The fragments ospA4, ospA5, ospA6 and ospA7 were created as illustrated in Fig. 2
and were cloned into pBBE22. The DRs and the T-rich region are collectively designated cisI. cisII represents the sequence
between the ”10 region and the start codon.
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(P50.02). These data indicate that the presence of the T-rich
region increases ospA expression and that the inclusion of
the sequence of direct repeats (DRs) further enhances
expression in B. burgdorferi grown in vitro. The current study
was unable to rule out whether the T-rich region and DRs
functioned as a single regulatory element or two independent
units, so they were collectively designated cisI.
Next, groups of three SCID mice were inoculated with
clone DospA/ospA1/1, DospA/ospA1/2, DospA/ospA2/1,
DospA/ospA2/2, DospA/ospA3/1 or DospA/ospA3/2. Only 2
of the 18 inoculated animals were infected when mice were
euthanized 1 month post-inoculation (data not shown).
The inability to fully restore infectivity of DospA prevented
us from using its derivatives in animal studies.
Fortunately, the native ospAB operon is not expressed by B.
burgdorferi during mammalian infection; therefore its
presence should not affect the behaviour of an introduced
construct that may drive ospA expression. The constructs
pBBE22-ospA1 to pBBE22-ospA3 were electroporated into
Fig. 2. Creation of fragments ospA4 (A), ospA5 (B), ospA6 (C) and ospA7 (D). Details of the constructions are described in
Methods.
ospAB regulatory elements
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13A/ospA2/1, 13A/ospA2/2, 13A/ospA3/1 and 13A/ospA3/2,
were selected for the study as they had the same plasmid
content, including having lost cp9, lp21 and lp5, in
addition to lp25 and lp56. Subgroups of three SCID mice
were inoculated with each of these clones. An additional 12
mice were challenged with clone 5A11 or 13A/E22/C as
controls. Clone 5A11 contains 20 plasmids, lacks lp5, and is
considered to have a wild-type phenotype (Purser &
Norris, 2000); clone 13A/E22/C has the same plasmid
content as the six test clones and was generated via
introduction of pBBE22 into clone 13A in our previous
study (Xu et al., 2007b). The two controls were used to
assess whether the lack of cp9, lp21, lp5, lp25 and lp56
affected ospA expression in mice. Evidence of joint swelling
in all 30 mice occurred within 12 days after inoculation
and quickly developed into severe arthritis (data not
shown), indicating that all the clones were infectious in
SCID mice.
All mice were euthanized 1 month post-inoculation; RNA
was prepared from skin specimens and assessed for the
relative copy numbers of ospA and flaB mRNAs by RT-
qPCR. As shown in Fig. 3(C), both 5A11 and 13A/E22/C
spirochaetes expressed ospA at a baseline level (P50.67),
indicating that the absence of cp9, lp21, lp5, lp25 and lp56
does not affect ospA regulation in vivo. There was also no
significant difference in ospA expression detected in the
genotypes 13A/E22 and 13A/ospA1 (P50.74). When a gene
is expressed at an extremely low level, RT-qPCR data may
only reflect ‘noise’. This could be the reason why the 13A/
ospA1 spirochaetes did not show increased ospA expression
although they contained a construct-source ospA copy in
addition to the native gene. Nevertheless, these data
indicate that the presence of the native ospA copy does
not interfere with data interpretation in our system.
When the three genotypes harbouring an ospA construct
were compared for ospA expression in skin, the genotype
13A/ospA1 accumulated ospA transcripts at a 17.3- and
18.0-fold lower level than the genotypes 13A/ospA2
(P52.9610
23) and 13A/ospA3 (P52.7610
25), respect-
ively (Fig. 3C); but there was no significant difference in
ospA expression between the latter two genotypes
Fig. 3. The presence of DRs and the T-rich region enhances ospA
expression in vitro but reduces expression in mice. (A) Restoration
of OspA synthesis resulting from introduction of a construct. 13A,
DospA, DospA/ospA1/1, DospA/ospA1/2, DospA/ospA2/1,
DospA/ospA2/2, DospA/ospA3/1 and DospA/ospA3/2 spiro-
chaetes were harvested at late-exponential phase and subjected
to immunoblot analysis, probed with a mixture of FlaB and OspA
mAbs. (B) Deletion of cisI and the T-rich region causes reduced
ospA expression in vitro. DospA/ospA1/1, DospA/ospA1/2,
DospA/ospA2/1, DospA/ospA2/2, DospA/ospA3/1 and DospA/
ospA3/2 spirochaetes were harvested at late-exponential phase in
duplicate. RNA was prepared and analysed for ospA and flaB
expression by RT-qPCR. The expression activity is presented as
ospA mRNA copy numbers per 10
3 flaB transcripts. For
comparison, the subgroups were combined into three groups:
DospA/ospA1/1 and DospA/ospA1/2, DospA/ospA2/1 and
DospA/ospA2/2, and DospA/ospA3/1 and DospA/ospA3/2. The
mean copy numbers (horizontal lines) for each group are
presented. (C) The sequence of DRs is involved in repressing
ospA expression in vivo. Subgroups of three SCID mice were
inoculated with clone 13A/ospA1/1, 13A/ospA1/2, 13A/ospA2/1,
13A/ospA2/2, 13A/ospA3/1 or 13A/ospA3/2, and an additional
12 mice were infected with clones 5A11 and 13A/E22/C. All
animals were euthanized 1 month later. RNA was extracted from
skin specimens and quantified for flaB and ospA mRNAs by RT-
qPCR. Data are presented as ospA transcripts per 10
3 flaB mRNA
copies in five groups (genotypes including 5A11, 13A/E22, 13A/
ospA1, 13A/ospA2 and 13A/ospA3). The means (horizontal lines)
for each group are also presented.
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for these genotypes when RNA prepared from the heart
and joint specimens was analysed (data not shown). These
data indicated that the sequence upstream of the ospAB
promoter, which includes at least DRs, functions as a cis
element critical for repressing ospA expression in mice.
Although our data are not indicative of the T-rich region
being a part of the regulatory element, our study cannot
rule out its involvement, as the deletion of the DRs alone
may completely destroy the integrity of the unit. This is a
reason why both the T-rich region and the DRs are
collectively termed cisI.
Replacement of cisII with the corresponding
sequence of the ospC gene leads to decreased
ospA mRNA accumulation in vitro but increased
accumulation in mice
Surprisingly, the construct pBBE22-ospA3 carried the
minimum ospAB promoter but drove significant ospA
expression in murine tissues, albeit initiating much lower
expression than the flaB promoter that was fused with the
ospA reporter gene (Xu et al., 2008a), leading us to
hypothesize that other sequences adjacent to the ospAB
promoter may also be involved in repression of ospA
expression. To examine this hypothesis, we focused on the
sequence between the minimal ospAB promoter and the
start codon ATG, which was collectively designated cisII.
To this end, construct pBBE22-ospA4 was generated as
illustrated in Figs 1 and 2. Within this construct, cisII was
replaced with the corresponding region of ospC (the
sequence between the 210 region of the ospC promoter
and the start codon of the ospC gene), which was selected
based on a previous study showing its non-involvement in
gene regulation (Xu et al., 2007a). The construct was first
electroporated into DospA to examine whether this
modification affected the activity of the ospA promoter in
vitro. Two clones, DospA/ospA4/1 and DospA/ospA4/2,
which shared the same plasmid content as DospA, were
selected for the study. An immunoblot analysis showed
that the construct conferred OspA production at a level
slightly lower than that of pBBE22-ospA3 (Fig. 4A).
Next, RNA was prepared and analysed for ospA and flaB
expression by RT-qPCR. Clone DospA/ospA3 produced
72% more ospA transcripts than DospA/ospA4
Fig. 4. The sequence cisII contributes to increased ospA
expression in vitro but decreased expression in mice. (A)
Restoration of OspA synthesis resulting from introduction of
pBBE22-ospA4. 13A, DospA, DospA/ospA3/1, DospA/ospA3/2,
DospA/ospA4/1 and DospA/ospA4/2 spirochaetes were har-
vested at late-exponential phase and subjected to immunoblot
analysis, probed with a mixture of FlaB and OspA mAbs. (B) The
sequence cisII significantly contributes to ospA mRNA accumula-
tion in vitro. DospA/ospA3/1, DospA/ospA3/2, DospA/ospA4/1
and DospA/ospA4/2 spirochaetes were harvested at late-expo-
nential phase in duplicate; RNA was extracted and analysed for
ospA and flaB expression by RT-qPCR. The expression activity is
presented as ospA mRNA copy numbers per 10
3 flaB transcripts
in two groups (combining the subgroups), DospA/ospA3/1 and
DospA/ospA3/2, and DospA/ospA4/1 and DospA/ospA4/2. The
mean copy numbers (horizontal lines) for each group are
presented. (C) The sequence cisII contributes to the down-
regulation of ospA expression in vivo. Subgroups of three mice
were inoculated with clone 13A/ospA3/1, 13A/ospA3/2, 13A/
ospA4/1 or 13A/ospA4/2. Mice were euthanized 1 month later;
RNA was extracted from skin specimens and quantified for flaB
and ospA expression by RT-qPCR. Data are presented as ospA
transcripts per 10
3 flaB mRNA copy numbers in two groups
(genotypes including 13A/ospA3 and 13A/ospA4). The means
(horizontal lines) for each group are also presented.
ospAB regulatory elements
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24) (Fig. 4B). Clearly, the replacement of cisII
with the corresponding sequence of the ospC gene led to a
significant reduction in ospA expression in vitro. However,
this piece of data alone does not necessarily suggest that the
modification reduces the activity of the ospAB promoter.
Alternatively, cisII may play an important role in enhancing
ospA expression in vitro.
To examine the influence of cisII on ospA expression in
vivo, pBBE22-ospA4 was electroporated into 13A spiro-
chaetes. Two clones, 13A/ospA4/1 and 13A/ospA4/2, shared
the same plasmid content as the genotypes 13A/ospA1,
13A/ospA2 and 13A/ospA3, and were inoculated into six
SCID mice. An additional six mice were inoculated with
clone 13A/ospA3/1 or 13A/ospA3/2 as a control. Mice were
euthanized 1 month post-inoculation, and RNA was
prepared from skin specimens and analysed. As shown in
Fig. 4(C), the genotype 13A/ospA4 produced 8.6-fold
more ospA transcripts than the genotype 13A/ospA3
(P56.5610
26). Similar ospA expression patterns were
noted for these genotypes when heart and joint RNA
preparations were analysed (data not shown). The data
indicated that the ospA promoter can drive active gene
expression in the murine host once cisII is substituted, thus
suggesting that cisII contributes to the downregulation of
ospA expression in the murine host.
Confirmation of the role of both cisI and cisII in
enhancing ospA expression in vitro but reducing
its expression in mice by using the flaB reporter
promoter
In a previous study, we created a construct, pBBE22-ospA9,
by fusing the flaB promoter with a promoterless ospA,
demonstrating that it drove active ospA expression both in
vitro and in vivo (Xu et al., 2008a). In the current study, we
used the same system to confirm the role of cisI and cisII in
ospA regulation through generation of three constructs,
pBBE22-ospA5 to pBBE22-ospA7. In pBBE22-ospA5, cisI
was directly fused with the flaB promoter, aimed at
confirmation of the influence of cisI on the activity of a
downstream promoter. In pBBE22-ospA6, cisII was inserted
between the flaB promoter and the ospA reporter gene, a
construct that would allow us to further examine whether
cisII can influence downstream gene expression. In
pBBE22-ospA7, cisI and cisII were, respectively, inserted
immediately upstream and downstream of the flaB reporter
promoter, in order to investigate whether the two cis
elements have a synergistic effect on gene regulation.
These three constructs were first electroporated into DospA
to investigate whether the two cis elements contribute to
ospA regulation in vitro. As a control, pBBE22-ospA9 was
also electroporated into DospA. Eight clones, namely
DospA/ospA5/1, DospA/ospA5/2, DospA/ospA6/1, DospA/
ospA6/2, DospA/ospA7/1, DospA/ospA7/2, DospA/ospA9/1
and DospA/ospA9/2, were selected for the study as they
had the same plasmid content as DospA. An immunoblot
analysis indicated that all three flaB promoter derivatives
drove abundant OspA production (Fig. 5A).
RNA was prepared from spirochaetes harvested at late-
exponential phase and analysed by RT-qPCR. As shown in
Fig. 5(B), the genotype DospA/ospA9 accumulated 28% and
141% less ospA transcripts than the genotypes DospA/
ospA5 (P50.008) and DospA/ospA6 (P54.1610
26),
respectively, confirming the role of both cis elements in
enhancing ospA expression in vitro. Moreover, the
genotype DospA/ospA6 produced 88% more ospA mRNA
than the genotype DospA/ospA5 (P52.1610
25), indicating
that cisII increases ospA accumulation more effectively than
cisI. Finally, the genotype DospA/ospA7 accumulated 189%,
126% and 20% more ospA mRNA than the genotypes
DospA/ospA9 (P59.3610
26), DospA/ospA5 (P52.7610
25)
and DospA/ospA6 (P,0.02), respectively, indicating that
cisI and cisII function synergistically in enhancing ospA
expression in cultivated B. burgdorferi.
To confirm the role of both cisI and cisII in ospA regulation
in vivo, the four constructs were electroporated into 13A
spirochaetes. Eight clones, 13A/ospA5/1, 13A/ospA5/2, 13A/
ospA6/1, 13A/ospA6/2, 13A/ospA7/1, 13A/ospA7/2, 13A/
ospA9/1 and 13A /ospA9/2, were selected to challenge
subgroups of three SCID mice. These clones contained the
same plasmids as the genotypes 13A/ospA1, 13A/ospA2,
13A/ospA3 and 13A/ospA4. Mice were euthanized 1 month
post-inoculation; skin RNA was prepared and analysed. As
shown in Fig. 5(C), the genotype 13A/ospA5 accumulated
twofold less ospA transcripts than the control 13A/ospA9
(P52.9610
29), thus confirming the role of cisI in
repressing ospA expression in vivo. The genotype 13A/
ospA6 accumulated 7.3 times less ospA transcripts than the
control 13A/ospA9 (P52.2610
29), confirming the contri-
bution of cisII to the downregulation of ospA expression.
When the genotypes 13A/ospA5 and 13A/ospA6 were
compared, the former expressed 4.1-fold higher ospA
transcripts than the latter (P59.7610
28), indicating that
cisII more effectively contributes to ospA repression than
cisI.
When both cisI and cisII were simultaneously fused with
the flaB promoter, upstream and downstream, respectively,
their contribution to ospA repression was further con-
firmed (Fig. 5C): the genotype 13A/ospA7 produced 64
times less ospA transcripts than the genotype 13A/ospA5
(P56.1610
28). It expressed 18-fold less ospA mRNA than
the genotype 13A/ospA6 (P52.0610
26). Overall, the
collective effect of the two cis elements reduced ospA
expression by 129-fold (P53.5610
210), when 13A/ospA9
and 13A/ospA7 were compared.
DISCUSSION
Although controversies surround the exact functions of
OspA and OspB in the tick, abundant production of these
surface lipoproteins is crucial for B. burgdorferi to colonize
the vector during its natural life cycle (Battisti et al., 2008;
Q. Xu, K. McShan and F. T. Liang
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Moreover, the downregulation of the ospAB operon is
critical for the pathogen to effectively evade the immune
system, cause persistent infection, and maintain the
enzootic cycle (Strother et al., 2007; Tsao et al., 2001,
2004; Xu et al., 2008a). The molecular mechanisms by
which B. burgdorferi dramatically changes OspA/B expres-
sion during cycling between the two distinct hosts
remained largely unknown, until this study carefully
analysed the elements surrounding the ospAB promoter,
showing involvement of sequences both upstream and
downstream of the promoter in the regulation of ospA
expression.
During the past 3 years, we have generated three ospAB
mutants, and all lack the expected infectivity following
complementation. These mutants were thinner and less
motile than the wild-type, growing very poorly while
aggregating at the bottom of culture tubes during in vitro
cultivation, essentially consistent with a report by Sadziene
et al. (1995) describing severe growth defects of OspAB-
deficient B. burgdorferi. In contrast, we successfully
inactivated ospC, dbpAB, and rpoS without difficulty using
the same system, readily restoring these mutants to full
infectivity (Shi et al., 2008; Xu et al., 2007a). Because both
OspA and OspB are such highly produced outer-surface
lipoproteins in cultivated B. burgdorferi, inactivation of the
ospAB operon may cause a severe compromise in the
integrity of the outer-surface lipoprotein layer, conse-
quently severely affecting spirochaete survival. The ospAB
mutants selected most likely underwent dramatic changes
in gene expression to compensate for the loss of OspA/B.
To date, three groups have generated infectious ospAB or
ospB mutants (Battisti et al., 2008; Neelakanta et al., 2007;
Yang et al., 2004), but concluded differing roles for OspA/B
during the life cycle of B. burgdorferi in the tick vector.
While different tick-feeding techniques used in their
studies could be an explanation for these disparities, as
discussed by Battisti et al. (2008), the fact that each group
used different mutants should also be considered, as the
current study shows derivatives of the ospAB mutant
producing inconsistent results following inoculation into
mice. A recent study by He et al. (2008) reported two
Fig. 5. Confirmation of the role of cisI and cisII in enhancing ospA
expression in vitro but reducing expression in vivo. (A) Restoration
of OspA synthesis resulting from introduction of pBBE22-ospA5,
pBBE22-ospA6 or pBBE22-ospA7. DospA, DospA/ospA9/1,
DospA/ospA9/2, DospA/ospA5/1, DospA/ospA5/2, DospA/
ospA6/1, DospA/ospA6/2, DospA/ospA7/1 and DospA/ospA7/2
spirochaetes were harvested at late-exponential phase and
subjected to immunoblot analysis, probed with a mixture of FlaB
and OspA mAbs. (B) Confirmation of the role of cisI and cisII in
enhancing ospA expression in vitro. DospA/ospA9/1, DospA/
ospA9/2, DospA/ospA5/1, DospA/ospA5/2, DospA/ospA6/1,
DospA/ospA6/2, DospA/ospA7/1 and DospA/ospA7/2 spiro-
chaetes were harvested at late-exponential phase in duplicate.
RNA was extracted and analysed for ospA and flaB mRNA
accumulation by RT-qPCR. The expression activity is presented as
ospA mRNA copy numbers per 10
3 flaB transcripts and compared
in four groups by combining the subgroups DospA/ospA9/1 and
DospA/ospA9/2, DospA/ospA5/1 and DospA/ospA5/2, DospA/
ospA6/1 and DospA/ospA6/2, and DospA/ospA7/1 and DospA/
ospA7/2. The mean copy numbers (horizontal lines) for each group
are also presented. (C) Confirmation of the contributions of cisI
and cisII to the downregulation of ospA expression in vivo.
Subgroups of three mice were inoculated with clone 13A/ospA9/1,
13A/ospA9/2, 13A/ospA5/1, 13A/ospA5/2, 13A/ospA6/1, 13A/
ospA6/2, 13A/ospA7/1 or 13A/ospA7/2 and euthanized 1 month
later. RNA was extracted from skin specimens and quantified for
flaB and ospA expression by RT-qPCR. Data are presented as
ospA transcripts per 10
3 flaB mRNA copies in four groups
(genotypes including 13A/ospA9, 13A/ospA5, 13A/ospA6 and
13A/ospA7). The means (horizontal lines) for each group are also
presented.
ospAB regulatory elements
http://mic.sgmjournals.org 2201phenotypes of the ospA mutant: one with constitutive ospC
expression and the other having lost the ability to induce
ospC expression in response to environmental changes.
Our ospAB mutant exhibits a third phenotype, the ospC
expression pattern of wild-type B. burgdorferi (Xu et al.,
2008b).
Deletion of the DRs resulted in decreased ospA expression in
vitro, and further removal of the T-rich region led to an
additional reduction, suggesting that both sequences are
involved in positive regulation of ospA expression in vitro.
However, our study could not determine whether DRs and
the T-rich region function independently or act collectively
as a single regulatory element; hence they were designated
cisI. The identification of the cis element predicts the
existence of regulatory protein(s) called activator(s). Further
identification of these unknown regulator(s) should help
solve the puzzle of whether DRs and the T-rich region
constitutea singleregulatory unit.Toconfirmtheregulatory
function of cisI, it wasusedto replacethe upstream sequence
of the flaB promoter and was shown to significantly increase
expression of an ospA reporter gene in vitro.
Exactly opposite to what was observed in vitro, deletion of
the DRs caused a significant increase in ospA expression in
the murine host, indicating that the sequence is involved in
repressing ospA expression in vivo. Although further
removal of the T-rich region did not affect ospA expression
in murine tissues, our study could not rule out whether the
region and DRs collectively form a regulatory element
because deletion of DRs alone may destroy its function.
The regulatory function of cisI, which includes both the
DRs and the T-rich region, in mammalian hosts was
further confirmed by using the flaB reporter promoter. cisI
is likely to function as an operator, whose identification
predicts the existence of a regulator named repressor.
Further identification of the unknown regulator should
help determine whether the T-rich region is a part of the
operator of B. burgdorferi during mammalian infection.
Sohaskey et al. (1999) showed that deletion of the T-rich
region results in a great reduction in expression of a
chloramphenicol acetyltransferase reporter gene in vitro,
while Caimano et al. (2007) suggested that this sequence
may be involved in the downregulation of ospA/B in the
mammalian host. The current study clearly confirmed the
findings of Sohaskey et al. (1999) when B. burgdorferi was
grown in vitro. However, we could not confirm the T-rich
region as a part of the regulatory element of this
spirochaete during mammalian infection.
Because the downstream sequence, collectively called cisII,
of the ospAB promoter contains the transcriptional
initiation site and ribosome-binding site, it cannot simply
be deleted in order to investigate its regulatory function.
The replacement of cisII caused a significant decrease in
ospA expression in vitro, indicating a role of the sequence in
enhancing expression. This role was further confirmed via
fusion of cisII with the flaB reporter promoter. An opposite
function of cisII was revealed in B. burgdorferi during
murine infection. Like cisI, cisII may function as an
operator interacting with an as-yet-unidentified repressor
and contribute to ospAB downregulation in the mam-
malian host. Given that activator sites are usually located
upstream of the 210 region (Collado-Vides et al., 1991)
and that cisII is sited between the 210 region and the start
codon, with most of its sequence being transcribed into
mRNA, it may be involved in post-transcriptional rather
than transcriptional regulation (Lucchetti-Miganeh et al.,
2008), when B. burgdorferi is grown in vitro. The RNA
sequence transcribed from cisII may interact with an as-
yet-unidentified RNA-binding protein, and consequently
lead to protection of ospAB transcripts when B. burgdorferi
is grown in vitro. RNA-binding protein may also have an
opposite function, which is to facilitate RNA turnover and
subsequently cause gene downregulation (Lucchetti-
Miganeh et al., 2008). From this point of view, cisII does
not necessarily function as an operator in B. burgdorferi
during murine infection, but instead its RNA sequence may
interact with a specific RNA-binding protein and, as a
consequence, facilitate mRNA degradation. Interestingly,
our previous study noted that the 39 sequence (ospB
portion) of ospAB mRNA is more stable than the 59 (ospA)
portion in murine tissues but less stable when spirochaetes
are grown in vitro (Liang et al., 2004a). It remains to be
addressed whether this differential degradation of ospA and
ospB portions of the bicistronic mRNA is due to a function
of cisII.
The identification of the regulatory structure provided
insights into the complexity of ospAB regulation. During in
vitro cultivation, this currently unidentified activator is
induced, which may enhance ospAB expression through an
interaction with cisI. To further increase expression, the in
vitro environment may also induce an unknown RNA-
binding protein, which binds to the specific RNA sequence
transcribed from cisII and protects ospAB mRNA. In
contrast, the mammalian environment may induce two
unidentified repressors, which bind to cisI and cisII,
respectively, and shut off the ospAB operon. The mam-
malian milieu may also induce an unknown RNA-binding
protein, which binds to the RNA sequence of cisII and
facilitates mRNA degradation to further minimize OspA/B
production. One could speculate that the unknown
activator and repressor may be the same regulators, whose
function is environment-dependent, and that the same
RNA-binding protein may protect ospAB mRNA in vitro
but facilitate decay during mammalian infection. Future
studies should help to resolve these interesting issues.
A previous study reported that the downregulation of ospA
is induced by IgG molecules (Hodzic et al., 2005), in
contrast to our earlier study showing that B. burgdorferi
effectively represses ospA expression during infection of
both SCID and immunocompetent mice (Liang et al.,
2004a). The current study clarified the issue of whether IgG
is required for the induction of the downregulation. When
cisI was removed and cisII was replaced, the ospA promoter
efficiently initiated ospA expression as the flaB promoter
Q. Xu, K. McShan and F. T. Liang
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when one of the elements was fused with the core flaB
promoter, expression of the ospA reporter gene was
dramatically reduced, and when both sequences were fused
with the promoter, the reporter was essentially shut off.
Given that IgG molecules were absent under each of these
situations, the current study allowed us to conclude that
the mammalian environment alone sufficiently induces
downregulation of the ospAB operon.
Both OspA and OspB are highly immunogenic, so even a
low level of expression may stimulate a significant humoral
response. Although the responses may not effectively target
spirochaetes with low OspA and OspB production in
mammalian tissues, once the organisms are acquired by a
tick vector, the surface antigens are greatly upregulated and
consequently become effective targets in a blood meal.
Thus, concealing OspA and OspB from the adaptive
immune system is crucial for maintaining the enzootic
cycle. The current study demonstrated that this ability
depends on the newly identified cis elements. Even more
importantly, the dual functions of these regulatory
sequences can potentially provide B. burgdorferi with a
greater advantage for quick adaptation to diverse environ-
ments during its enzootic life cycle travelling between the
two distinct hosts. During persistent infection of a
mammal, many outer-surface lipoproteins, including both
RpoS- and s
70-dependent gene products, are actively
produced (Liang et al., 2002, 2004b; Miller & Stevenson,
2006). Abundant surface lipoprotein expression is required
for stabilizing the outer membrane of B. burgdorferi against
innate defences (Xu et al., 2008b). Once acquired by the
vector, however, B. burgdorferi quickly downregulates rpoS
(Caimano et al., 2007) and consequently RpoS-dependent
genes, such as dbpA, dbpB, ospF and bbk32 (Eggers et al.,
2004; He et al., 2007; Hubner et al., 2001), as well as some
s
70-dependent genes such as vlsE and some erp genes
(Bykowski et al., 2006). A simple shift of cisI and cisII from
the repressing mode to the activating function would allow
B. burgdorferi to boost OspA/B production, effectively
maintain the integrity of its outer-surface lipoprotein layer,
and ultimately adapt to the new environment.
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